Vanguard Group »

Onkure Therapeutics Inc-a shares owned by Vanguard Group

Quarter-by-quarter ownership of Onkure Therapeutics Inc-a (OKUR) shares owned by Vanguard Group from 13F filings

Historical chart of Vanguard Group investment in Onkure Therapeutics Inc-a

Tip: Access up to 7 years of quarterly data

All positions including Onkure Therapeutics Inc-a held by Vanguard Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Onkure Therapeutics Inc-a by Vanguard Group

Quarter filed Position value Share count Share price at filing
2025-09-30 $1.9M 678k 2.75
2025-06-30 $1.7M 707k 2.39
2025-03-31 $3.0M 707k 4.30
2024-12-31 $6.1M 707k 8.60

More positions owned by Vanguard Group

NVIDIA Corporation (NVDA)
Microsoft Corporation (MSFT)
Apple (AAPL)
Amazon (AMZN)
Broadcom (AVGO)
Meta Platforms Cl A (META)
Alphabet Cap Stk Cl A (GOOGL)
Tesla Motors (TSLA)
Alphabet Cap Stk Cl C (GOOG)
JPMorgan Chase & Co. (JPM)
Berkshire Hathaway Inc Del Cl B New (BRK.B)
Eli Lilly & Co. (LLY)
Visa Com Cl A (V)
Exxon Mobil Corporation (XOM)
Oracle Corporation (ORCL)

View all positions for Vanguard Group

Top funds holding Onkure Therapeutics Inc-a

Acorn Capital Advisors
Citadel Advisors
Shay Capital
Vanguard Group
Highbridge Capital Management
Vestal Point Capital
BlackRock
StepStone
Cantor Fitzgerald, L. P.
NEA Management Company
Carlyle
Prosight Management
Renaissance Technologies
Rangeley Capital
Tang Capital Management

View all funds holding Onkure Therapeutics Inc-a